tazemetostat
Showing 26 - 40 of 40
Diffuse Large B Cell Lymphoma, Primary Mediastinal Lymphoma, Mantle Cell Lymphoma Trial in Tucson, Tampa, New York
Completed
- Diffuse Large B Cell Lymphoma
- +4 more
- Tazemetostat
- +3 more
-
Tucson, Arizona
- +2 more
Mar 23, 2021
Advanced Soft Tissue Sarcoma, Advanced Epithelioid Sarcoma Trial in Worldwide (Tazemetostat, Placebo, Doxorubicin HCl)
Recruiting
- Advanced Soft Tissue Sarcoma
- Advanced Epithelioid Sarcoma
- Tazemetostat
- +2 more
-
Duarte, California
- +20 more
Jan 31, 2022
Follicular Lymphoma, Non Hodgkin Lymphoma, Lymphoma Trial in Edmonds, Issaquah, Seattle (Tazemetostat, Rituximab)
Terminated
- Follicular Lymphoma
- +2 more
- Tazemetostat
- Rituximab
-
Edmonds, Washington
- +2 more
Mar 1, 2021
Lymphoma, DLBCL, Follicular Lymphoma Trial in Belgium, France (Tazemetostat, Rituximab, Cyclophosphamide)
Recruiting
- Lymphoma
- +2 more
- Tazemetostat
- +5 more
-
Bruxelles, Belgium
- +30 more
Jul 23, 2021
Mesothelioma, BAP1 Loss of Function Trial in France, United Kingdom, United States (Tazemetostat)
Completed
- Mesothelioma
- BAP1 Loss of Function
- Tazemetostat
-
Los Angeles, California
- +15 more
Mar 16, 2021
Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6
Not yet recruiting
- Grade 3b Follicular Lymphoma
- +5 more
- Biospecimen Collection
- +9 more
- (no location specified)
Jun 6, 2023
Rhabdoid Tumors, INI1-negative Tumors, Synovial Sarcoma Trial in Worldwide (Tazemetostat)
Completed
- Rhabdoid Tumors
- +3 more
- Tazemetostat
-
Los Angeles, California
- +34 more
Dec 23, 2021
Epithelioid Sarcoma Trial (Tazemetostat)
No longer available
- Epithelioid Sarcoma
- Tazemetostat
- (no location specified)
Mar 4, 2020
Relapsed or Refractory Follicular Lymphoma With Enhancer of
Recruiting
- Lymphoma, Follicular
- Tazemetostat
-
Anjo-shi, Aichi, Japan
- +174 more
Dec 12, 2022
Recurrent Endometrial Endometrioid Adenocarcinoma, Recurrent Ovarian Carcinoma, Recurrent Ovarian Clear Cell Adenocarcinoma
Active, not recruiting
- Recurrent Endometrial Endometrioid Adenocarcinoma
- +4 more
- Tazemetostat
-
Anchorage, Alaska
- +584 more
Jan 28, 2023
Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma, Metastatic Malignant Solid
Withdrawn
- Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma
- +10 more
- Laboratory Biomarker Analysis
- +2 more
-
Baltimore, MarylandJohns Hopkins University/Sidney Kimmel Cancer Center
Feb 6, 2020
Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in
Recruiting
- Advanced Malignant Solid Neoplasm
- +44 more
- Biopsy
- +23 more
-
Birmingham, Alabama
- +166 more
Feb 2, 2023